Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
Authors
Keywords
Autism Spectrum Disorder, Risperidone, AMPA Receptor, Piracetam, Riluzole
Journal
PEDIATRIC DRUGS
Volume 15, Issue 6, Pages 505-514
Publisher
Springer Nature
Online
2013-07-02
DOI
10.1007/s40272-013-0036-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
- (2012) Ali Ghaleiha et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Interacting Partners of AMPA-Type Glutamate Receptors
- (2012) Juan Cheng et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- The NMDA receptor as a target for cognitive enhancement
- (2012) Graham L. Collingridge et al. NEUROPHARMACOLOGY
- Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
- (2012) Mahtab Asadabadi et al. PSYCHOPHARMACOLOGY
- Riluzole in Autistic Disorder
- (2011) Logan K. Wink et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders
- (2011) M. L. McPheeters et al. PEDIATRICS
- Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism
- (2011) Chie Shimmura et al. PLoS One
- The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities
- (2010) Ian R Mellor Future Medicinal Chemistry
- Increase in Valproic Acid Levels During Riluzole Treatment in an Adolescent with Autism
- (2010) Jeremy Veenstra-VanderWeele JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder
- (2010) Paul Grant et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder
- (2010) Vala Rezaei et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- P01-124 Riluzole for affective and behavioral disturbance in autism
- (2009) L. Wachtel EUROPEAN PSYCHIATRY
- Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
- (2009) Shahin Akhondzadeh et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders
- (2008) R. Blaylock et al. CURRENT MEDICINAL CHEMISTRY
- Riluzole in psychiatry: a systematic review of the literature
- (2008) Carlos A Zarate et al. Expert Opinion on Drug Metabolism & Toxicology
- The fraction of activated N-methyl-d-Aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole
- (2008) G. Rammes et al. JOURNAL OF NEURAL TRANSMISSION
- The hyperglutamatergic hypothesis of autism
- (2007) S.H. Fatemi PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started